MOHAMED ELNABARAWY

• Spearheaded hospital operations by developing and implementing comprehensive policies, resulting in 100% compliance with healthcare regulations and improved patient outcomes
• Enhanced operational efficiency by monitoring KPIs, identifying performance gaps, and executing targeted improvements, leading to a 20% reduction in patient waiting times.
• Directed resource allocation for a 75-bed facility, including staffing over 200 employees, budgeting, and supply chain optimization, achieving a 15% cost reduction without compromising patients care quality.
• Strengthened collaboration and communication by fostering strategic partnerships with physicians, staff, and stakeholders, which improved staff retention by 50% and patient satisfaction scores by 25%
• Executed strategic plans aligned with Board of directors objectives, scaling ICU capacity by 25% and increasing dialysis treatments by 30%

• Boosted patient satisfaction scores by 30% by implementing a patient-centered care model, streamlining admission processes, and enhancing communication between caregivers and patients
• Achieved 100% compliance with regulatory requirements and accreditation standards by introducing robust monitoring systems and staff training programs
• Led a team of over 300 employees, optimizing workflows and resources to accommodate a 15% increase in patient admissions while maintaining high-quality care for financially challenged patients
• Drove the expansion of ICU capacity by 40%, improving critical care response time & outcomes for patients.

• Achieved a 20% revenue increase by developing and executing a long-term organizational strategy focused on market expansion and operational efficiency and improve employees engagements and reduced turn over by 50%
• Streamlined resource allocation and performance tracking for a multi-department team, resulting in a 25% improvement in team productivity and adherence to project timelines
• Improved financial forecasting accuracy by 75% through enhanced budget analysis and real-time supply chain monitoring, leading to better cash flow management and reduced operational risks
• Identified critical business weaknesses and implemented targeted initiatives, such as cross-departmental training.

• Achieved a 100% compliance rate in delivering balanced scientific information by leading and mentoring a team of Medical Science Liaisons that enhanced stakeholder trust and loyalty
• Increased the efficiency of promotional material approval processes by 25% through the implementation of protocols aligned with regulatory standards
• Supported business development projects by providing medical guidance that leads to a 20% growth in portfolio expansion
• Reduced regulatory risk by 20% through rigorous risk assessments, implementation of targeted action plans, and effective management of HCP agreements and sponsorship approvals

• Expanded market penetration of niche biotech products resulting in a 50% increase in patient access to life-saving treatments
• Led a high-performing team of Medical Science Liaisons achieving a 100% success rate in delivering targeted educational programs to healthcare professionals
• Successfully managed budgets and resources for pre-launch and launch activities, ensuring timely product rollout and exceeding initial market adoption targets by 15%
• Ensured regulatory compliance by reviewing and approving promotional materials, reducing approval cycle times by 30% without compromising quality or compliance standards

• Supporting Marketing, Sales & Regulatory teams by addressing medical inquiries to achieve company objectives
• Played a crucial role in prelaunch and launch activities, including Advisory Boards, satellite symposia, and standalone meeting
• Maintenance of scientific leaders, coordinating with international speakers for lecture tours in alignment with marketing strategies and plans

• Increased market share for Dyslipidemia products by 20% through targeted sales strategies tailored to private sector, institutions & MOH
• Streamlined marketing initiatives that leads to a 25% boost in product awareness among healthcare professionals.
• Enhanced sales team performance by delivering specialized training on Dyslipidemia treatment protocols, achieving 35% increase in overall sales rates.

• Achieved a 45% increase in regional sales, surpassing the $18M target, by implementing targeted sales strategies and optimizing team performance across multiple therapeutic areas
• Led and motivated a team of 22 Pharmaceutical Sales Representatives, delivering specialized training programs that resulted in a 30% improvement in sales productivity and customer engagement

Best achiever kingdom with 120% target& 2 digit market share for 3 consecutive years.

Man of the year 1998 & best achiever with 110% target for 3 years in rows.